Erba Molecular makes a quality decision


Erba Molecular continues the expansion of its team with the appointment of Dr Sarah Mardle as Director of Quality & Operations.

Erba Molecular (previously known as Lumora Limited), a successful provider of state-of-the-art molecular diagnostic products into both the clinical and industrial markets, is pleased to announce that it has appointed Dr Sarah Mardle as Director of Quality & Operations.

Sarah will be responsible for leading and managing the strategic and operational performance of the Quality and Operations department, specifically working towards ISO13485 compliance. Prior to working for Erba Molecular, Sarah was employed by Baxter Inc, where she was responsible for the Compounding Unit (manufacturing chemotherapy, antibiotics, total parenteral nutrition pharmaceuticals) compliance to GMP standards as part of the site leadership team, in addition to managing the QA, QC and microbiology teams.  Prior to working at Baxter, Sarah held senior QA and Operations positions at Biocair and Abcam.

Sarah joins a growing team at Erba Molecular’s Ely based facility which in 2016 has seen a number of new R&D appointments including that of Vivian Jonas, Senior Director of Development, a TB and mycobacterial expert with over thirty years of infectious disease molecular diagnostics experience.

Commenting on the new appointment Laurence Tisi, Chief Executive Officer of Erba Molecular said “Sarah is a fantastic addition to the team.  Her regulatory standards knowledge coupled with her extensive operational experience in rapidly expanding biotech companies will enable us to deliver quickly our growing molecular diagnostics product development pipeline in a regulatory framework.  2016 has been a pivotal year of growth for the company, putting us in an optimum position for delivering on our objectives in 2017”.

Sarah commented “I am delighted to join the Erba team and look forward to working at the cutting edge of science to develop innovative diagnostics”.

Sarah has a Neuroscience PhD from King’s College London and a BSc Double Honours Biochemistry & Pharmacology from the University of Southampton.


About Erba Molecular

Erba Molecular (previously known as Lumora Ltd) is a successful provider of state-of-the-art molecular diagnostic products into both the clinical and non clinical or industrial markets.  In September 2015, Lumora Ltd was acquired by Erba Diagnostics Mannheim a fully integrated global in vitro diagnostics company, offering a comprehensive suite of clinical testing products to the growing number of smaller hospitals, reference labs, and physician clinics in the developed and emerging markets with reliable, affordable and innovative health care products. Erba Diagnostics Mannheim is based in Mannheim, Germany and serves more than 25,000 customers spread across 100+ countries through its 1500+ committed employees and an extensive distributor network.

For more information, please visit:




ERBA Molecular is a successful and innovative molecular IVD company applying its commercially validated proprietary technology in sample preparation, amplification and detection to produce novel workflow based solutions to reduce the complexity of molecular testing. ERBA Molecular was created by the acquistion of Lumora Ltd in September 2015 by ERBA Mannheim GmbH.

Erba Molecular